SCHEMBL29488643

SCHEMBL29488643

CCCn1nc(Cc2c(Cl)cc(N)cc2Cl)ccc1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 1/20 0.38
ALDH1A1 P00352 2/20 0.36
CYP2C19 P33261 3/20 0.36
CYP1A2 P05177 2/20 0.36
LMNA P02545 2/20 0.36
PTGDR2 Q9Y5Y4 7/20 0.35
GRIN2D O15399 1/20 0.32
GRIN3B O60391 1/20 0.32
GRIN1 Q05586 1/20 0.32
GRIN2A Q12879 1/20 0.32
GRIN2B Q13224 1/20 0.32
GRIN2C Q14957 1/20 0.32
GRIN3A Q8TCU5 1/20 0.32
CYP3A4 P08684 1/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
HPGD P15428 1/20 0.32
HSD17B10 Q99714 1/20 0.32
ADORA2A P29274 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29488641 0.89 PTGDR2 (0.36) CYP2C19CYP1A2PTGDR2CYP3A4CYP2D6
SCHEMBL29488656 0.80 PTGDR2 (0.53) ALDH1A1CYP2C19CYP1A2PTGDR2CYP3A4
SCHEMBL29488647 0.78 THRA (0.32) PTGDR2
SCHEMBL29488651 0.75 DPP4 (0.37)
SCHEMBL29488655 0.73 GAA (0.43) ALDH1A1LMNAKDM4EHSD17B10
SCHEMBL29488652 0.73 DPP4 (0.36) LMNACYP3A4CYP2D6
SCHEMBL10044415 0.71 PTGS2 (0.48) PTGS2ALDH1A1CYP2C19CYP1A2LMNA
SCHEMBL29488649 0.70 MAPT (0.40) CYP2C19CYP1A2LMNAPTGDR2CYP2D6
SCHEMBL29488638 0.68 NPBWR1 (0.39) ALDH1A1KDM4E
SCHEMBL29488644 0.68 KMT2A (0.47) CYP2C19CYP1A2CYP3A4HPGDPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022068915-A1 6-OXO-1,6-DIHYDROPYRIDAZIN DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF IN MEDICINE 江苏恒瑞医药股份有限公司 2022-04-07 WO disclosed